Stock TCRX TSCAN THERAPEUTICS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Press Releases TScan Therapeutics, Inc.

Equities

TCRX

US89854M1018

Market Closed - Nasdaq
Other stock markets
 04:00:00 2024-05-02 pm EDT 		5-day change 1st Jan Change
8.65 USD +0.35% Intraday chart for TScan Therapeutics, Inc. +18.66% +48.37%
Apr. 19 TScan Therapeutics Closes $150.1 Million Securities Offering MT
Apr. 17 TScan Therapeutics Prices $150.1 Million Public Offering of Shares, Warrants MT

Press Releases

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
TScan Therapeutics Announces Upcoming Presentations at the 2024 American Society of Clinical Oncology Annual Meeting
GL
TScan Therapeutics Announces Exercise of Underwriters' Option to Purchase Additional Shares
GL
TScan Therapeutics Announces Upcoming Presentations at the American Society of Gene and Cell Therapy 27th Annual Meeting
GL
TScan Therapeutics Announces Closing of Upsized Public Offering
AQ
TScan Therapeutics Announces Closing of Upsized Public Offering
GL
TScan Therapeutics Announces Pricing of Upsized $150 Million Public Offering
GL
TScan Therapeutics Announces Launch of $125 Million Proposed Public Offering
GL
TScan Therapeutics Provides Clinical Pipeline Update and Highlights Near-Term Priorities
GL
TScan Therapeutics Appoints Seasoned Hematology and Oncology Expert Chrystal U. Louis, M.D., M.P.H., as Chief Medical Officer
GL
TScan Therapeutics Appoints Seasoned Hematology and Oncology Expert Chrystal U. Louis, M.D., M.P.H., as Chief Medical Officer
AQ
TScan Therapeutics Announces Upcoming Presentation at the 23rd Annual Needham Virtual Healthcare Conference
GL
TScan Therapeutics Announces Upcoming Presentation at the 23rd Annual Needham Virtual Healthcare Conference
AQ
TScan Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update
GL
TScan Therapeutics to Participate in the TD Cowen 44th Annual Health Care Conference
GL
TScan Therapeutics to Participate in the TD Cowen 44th Annual Health Care Conference
AQ
TScan Therapeutics Presents Promising Updated Phase 1 Clinical Results on TSC-100 and TSC-101 at the 2024 Tandem Meetings of ASTCT and CIBMTR
GL
TScan Therapeutics Presents Promising Updated Phase 1 Clinical Results on TSC-100 and TSC-101 at the 2024 Tandem Meetings of ASTCT and CIBMTR
AQ
TScan Therapeutics to Host Virtual KOL Event to Discuss Updated Results from Phase 1 Heme Malignancies Study Presented at the 2024 Tandem Meetings of ASTCT and CIBMTR
GL
TScan Therapeutics Expands Clinical Team with the Appointment of Dawn Pinchasik, M.D., M.S., as Vice President, Clinical Development
GL
TScan Therapeutics Appoints Seasoned Industry Executive Jason A. Amello as Chief Financial Officer
GL
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. TCRX Stock
  4. News TScan Therapeutics, Inc.
  5. Press Releases